Quantum Biopharma-B Sub VotQNTM

13F holders, Q2 2025 (June 30)
17holders +3
6new positions
3sold out
$20.40avg. 13F price*

At the end of Q2 2025, 17 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings, up 3 from Q1 2025. 6 opened new positions and 3 sold out. The largest holders were UBS Group AG ($929K), AdvisorShares Investments LLC ($749K) and Virtu Financial LLC ($338K).

Company
Quantum Biopharma-B Sub Vot
CUSIP
74764Y205
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q3 2024: 12Q3 2024Q4 2024: 9Q4 2024Q1 2025: 14Q1 2025Q2 2025: 17Q2 2025Q3 2025: 17Q3 2025Q4 2025: 24Q4 2025Q1 2026: 25Q1 2026Q2 2026: 26Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions6$673K
Exits3$100K

All 13F filers, Q1 2025 → Q2 2025: 76,733 shares bought and 30,142 shares sold, net +46,591 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 17 holders

UBS Group AG 0.00% Add +2742.8% 45,883 $929K
AdvisorShares Investments LLC 0.14% Reduce -24.5% 36,990 $749K
Virtu Financial LLC 0.02% New 16,706 $338K
LPL Financial LLC 0.00% New 10,917 $221K
Steward Partners Investment Advisory, LLC 0.00% New 3,100 $80K
JPMorgan Chase & Co. 0.00% New 897 $18K
BNP Paribas Financial Markets 0.00% New 700 $14K
Tower Research Capital LLC (TRC) 0.00% Reduce -83.0% 544 $11K
Cetera Trust Company, N.A 0.00% No change 250 $5K
SBI Securities Co., Ltd. 0.00% Reduce -1.3% 155 $3K
Morgan Stanley 0.00% Reduce -94.8% 131 $3K
Royal Bank of Canada 0.00% Add +331.6% 82 $2K
Osaic Holdings, Inc. 0.00% New 80 $2K
Group One Trading LLC 0.00% Reduce -70.4% 34 $688
Federation des caisses Desjardins du Quebec 0.00% No change 28 $552
Activest Wealth Management 0.00% No change 15 $304
TD Waterhouse Canada Inc. 0.00% Add +50.0% 3 $57

"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.